Showing 8,081 - 8,100 results of 21,342 for search '(( significantly ((we decrease) OR (a decrease)) ) OR ( significant decrease decrease ))', query time: 0.50s Refine Results
  1. 8081

    Table 1_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.doc... by Yiping Cao (1229856)

    Published 2024
    “…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”
  2. 8082

    Image 1_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.tif by Yiping Cao (1229856)

    Published 2024
    “…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”
  3. 8083

    Image 2_Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors.tif by Yiping Cao (1229856)

    Published 2024
    “…Pharmacological activation of local PVT A<sub>2A</sub>R with its agonist CGS21680 induced significantly decreased 50% paw withdrawal threshold (50%PWTs) and paw withdrawal latency (PWLs), as measured by the Von Frey test and Hargreaves test in adult mice. …”
  4. 8084
  5. 8085
  6. 8086
  7. 8087
  8. 8088
  9. 8089
  10. 8090
  11. 8091

    (A) The overexpression of PRDX1 reduces the intracellular ROS level. by Jing Chen (4762)

    Published 2025
    “…After overexpression of chIRAP, the intensity of red fluorescence in mitochondria decreased significantly, while the green fluorescence increased significantly. …”
  12. 8092

    F05 demonstrates additive anti-tumor effects in combination with mAb therapy and reprograms M2 macrophages towards a phagocytotic phenotype. by Keifer G. Kurtz (21416918)

    Published 2025
    “…CD163 MFI is significantly decreased with F05 treatment (p = 0.0089, 55% decrease), but not 1H9 (p = 0.0828, 31% decrease) when compared to RITUX.…”
  13. 8093

    Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation by Huang-Ju Tu (630766)

    Published 2024
    “…Although the development of DYRK1A inhibitors has significantly advanced in recent years, the selectivity of these drugs remains a critical challenge, potentially impeding further progress. …”
  14. 8094

    Table 1_Microbial diversity and composition in the gut microbiome of patients during systemic inflammatory response syndrome: can we use gut bacteria as potential biomarkers to cha... by Rafaela Ramalho Guerra (22106579)

    Published 2025
    “…Early AT taxonomic profiling showed a decrease in Anaerobutyricum spp. and an increase in Holdemania spp. in the sepsis group. …”
  15. 8095
  16. 8096
  17. 8097
  18. 8098
  19. 8099
  20. 8100